PG
AVNS icon

PEAK6 Group’s Avanos Medical AVNS Stock Holding History

PEAK6 Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,000
Closed -$276K – 4289
2018
Q1 		$276K Sell
6,000
-17,000
-74% -$807K ﹤0.01% 3112
2017
Q4 		$1.06M Sell
23,000
-2,600
-10% -$119K ﹤0.01% 1869
2017
Q3 		$1.15M Buy
25,600
+19,600
+327% +$836K 0.01% 1840
2017
Q2 		$236K Buy
+6,000
New +$227K ﹤0.01% 3203
2017
Q1 		– Sell
-4,000
Closed -$148K – 4276
2016
Q4 		$148K Sell
4,000
-4,600
-53% -$164K ﹤0.01% 3581
2016
Q3 		$298K Buy
8,600
+4,000
+87% +$140K ﹤0.01% 2820
2016
Q2 		$150K Buy
4,600
+600
+15% +$18.4K ﹤0.01% 3343
2016
Q1 		$115K Buy
+4,000
New +$107K ﹤0.01% 3507
2015
Q3 		– Sell
-13,300
Closed -$539K – 5104
2015
Q2 		$539K Sell
13,300
-14,400
-52% -$646K ﹤0.01% 2686
2015
Q1 		$1.36M Sell
27,700
-19,100
-41% -$885K 0.01% 1582
2014
Q4 		$2.13M Buy
+46,800
New +$1.84M 0.02% 1279

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PEAK6 Group's AVNS Position: Q1 2017 in Review

PEAK6 Group sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 1,059 shares — an estimated $39K sold.

PEAK6 Group first reported a position in AVNS in Q2 2015 and held it in 3 quarters. The position peaked at $393K in Q2 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • PEAK6 Group reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 1,059 Avanos Medical shares in Q1 2017, an estimated $39K.
  • PEAK6 Group first reported a position in Avanos Medical in Q2 2015 and held it in 3 quarters.
  • PEAK6 Group's Avanos Medical position peaked at $393K in Q2 2015.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.